MYC and prostate cancer: Nuclear ERβ2 increases invasiveness of PC3 cells [14] and increases cellular proliferation and expression of Twist1 (TWIST1) and c-Myc (MYC) in both PC3 and 22Rv1 cells, indicating possible oncogenic roles of ERβ2 in prostate cancer [15].